Clinical Trial Update: Primary Care Identification Of Patients With Chronic Neuropathic Low Back Pain Study [Phase 4]

View source ↗

Summary

Phase 4 study on identifying patients with chronic neuropathic low back pain was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain
• Neuralgia

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Low Back Pain, Neuralgia | Phase 4 | Status: WITHDRAWN